Ignite Creation Date:
2024-06-16 @ 11:47 AM
Last Modification Date:
2024-10-26 @ 3:30 PM
Study NCT ID:
NCT06429176
Status:
RECRUITING
Last Update Posted:
2024-05-24
First Post:
2024-05-15
Brief Title:
Safety Tolerability Pharmacokinetics and Preliminary Efficacy of SPL84 in Patients With Cystic Fibrosis
Sponsor:
SpliSense Ltd
Organization:
SpliSense Ltd
Organization Data
Organization:
SpliSense Ltd
Class:
INDUSTRY
Study ID:
SPL84-002
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
SpliSense Ltd
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None